| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,118,600 | 1,095,600 | 1,069,500 | 1,093,900 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 1,095,600 | 1,069,500 | 1,093,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 532,000 | 902,000 | 883,300 | 658,900 | | Non Recurring |
-
|
-
|
-
| 9,300 | | Others | 490,600 | 111,300 | 120,800 | 64,400 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,200 | 82,300 | 65,400 | 361,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 96,000 | 82,300 | 65,400 | 361,300 | | Interest Expense | 31,900 | 32,700 | 23,200 | 23,700 | | Income Before Tax | 64,100 | 49,600 | 42,200 | 337,600 | | Income Tax Expense | 48,700 | 22,000 | 17,700 | 66,700 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,400 | 27,600 | 24,500 | 270,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (722,700) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,400 | 27,600 | 24,500 | (451,800) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,400 | $27,600 | $24,500 | ($451,800) |
|
1.27% Nasdaq 0.00%
Income Statement
